文献速递淋巴瘤

循环游离DNA 5-羟甲基胞嘧啶在弥漫大B细胞淋巴瘤中的预后意义

Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
PubMed 文献 · Blood Adv · 2019-01-01

An elevated level of circulating cell-free DNA (cfDNA) has been associated with tumor bulk and poor prognosis in diffuse large B-cell lymphoma (DLBCL), but the tumor-specific molecular alterations in cfDNA with prognostic significance remain unclear.…

要点

  • cfDNA 5hmC谱区分细胞起源并与分期、IPI等预后因素相关。
  • 29基因加权预后评分在预测EFS和OS上优于传统预后因素。

核心结论

  • 初诊DLBCL患者血浆cfDNA 5hmC特征与临床结局相关,可能提供微创预后评估新方法。

研究设计与样本

  • 采用5hmC-Seal化学标记技术检测血浆cfDNA全基因组5hmC谱。
  • 基于29个基因应用弹性网络正则化于Cox比例风险模型构建加权预后评分(wp-score)。

主要发现

  • cfDNA 5hmC呈组织特异性增强子分布,符合基因调控潜在作用。
  • cfDNA 5hmC谱随细胞起源不同而异,并与分期和IPI等临床预后因素相关。
  • wp-score在预测EFS和OS的预后准确性、敏感性、特异性上优于已有预后因素。

临床怎么用

  • 初诊时检测血浆cfDNA 5hmC谱并计算wp-score,或可辅助识别EFS和OS预后较差的高危DLBCL患者。

局限性

  • 样本量仅48例,来自单中心,结论需更大队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An elevated level of circulating cell-free DNA (cfDNA) has been associated with tumor bulk and poor prognosis in diffuse large B-cell lymphoma (DLBCL), but the tumor-specific molecular alterations in cfDNA with prognostic significance remain unclear. We investigated the association between 5-hydroxymethylcytosines (5hmC), a mark of active demethylation and gene activation, in cfDNA from blood plasma and prognosis in newly diagnosed DLBCL patients. We used 5hmC-Seal, a highly sensitive chemical labeling technique, to profile genome-wide 5hmC in plasma cfDNA from 48 DLBCL patients at the University of Chicago Medical Center between 2010 and 2013. Patients were followed through 31 December 2017. We found a distinct genomic distribution of 5hmC in cfDNA marking tissue-specific enhancers, consistent with their putative roles in gene regulation. The 5hmC profiles in cfDNA differed by cell of origin and were associated with clinical prognostic factors, including stage and the International Prognostic Index. We developed a 29 gene-based weighted prognostic score (wp-score) for predicting event-free survival (EFS) and overall survival (OS) by applying the elastic net regularization on the Cox proportional-hazards model. The wp-scores outperformed (eg, prognostic accuracy, sensitivity, specificity) established prognostic factors in predicting EFS and OS. In multivariate Cox models, patients with high wp-scores had worse EFS (hazard ratio, 9.17; 95% confidence interval, 2.01-41.89; P = .004) compared with those in the low-risk group. Our findings suggest that the 5hmC signatures in cfDNA at the time of diagnosis are associated with clinical outcomes and may provide a novel minimally invasive prognostic approach for DLBCL.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Chiu BC, Zhang Z, You Q, et al. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv. 2019. PMID: 31570490. doi:10.1182/bloodadvances.2019000175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。